haloperidol has been researched along with Amnesia in 12 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Amnesia: Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Physostigmine and aspartic acid, but not haloperidol, diminished ketamine amnesia, therefore ketamine impaired the interaction of cholinergic and glutamate/aspartatergic neurons of hippocampal areas." | 3.68 | [Pharmacological correction of ketamine-impaired spatial memory of rats]. ( Kovalev, GV; Kuleshova, IP; Sazhin, VA, 1990) |
| " The dose-response curve was bell-shaped which is typical for cognition enhancers." | 1.29 | PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. ( Maurice, T; Nabeshima, T; Parish, DW; Privat, A; Su, TP, 1994) |
| "Variables measured included length of coma, PTA, rehabilitation admission and discharge functional status, and CT scan results." | 1.27 | Agitation in closed head injury: haloperidol effects on rehabilitation outcome. ( Jellinek, HM; Rao, N; Woolston, DC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurice, T | 4 |
| Su, TP | 2 |
| Parish, DW | 1 |
| Nabeshima, T | 3 |
| Privat, A | 4 |
| Ukai, M | 2 |
| Kobayashi, T | 3 |
| Kameyama, T | 3 |
| Matsuno, K | 1 |
| Senda, T | 1 |
| Mita, S | 1 |
| Phan, VL | 1 |
| Noda, Y | 1 |
| Yamada, K | 1 |
| Bidzseranova, A | 1 |
| Penke, B | 1 |
| Tóth, G | 1 |
| Telegdy, G | 1 |
| Itoh, J | 1 |
| Kovalev, GV | 1 |
| Sazhin, VA | 1 |
| Kuleshova, IP | 1 |
| Vasar, EE | 1 |
| Allikmets, LKh | 1 |
| Soosaar, AKh | 1 |
| Rao, N | 1 |
| Jellinek, HM | 1 |
| Woolston, DC | 1 |
12 other studies available for haloperidol and Amnesia
| Article | Year |
|---|---|
PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice.
Topics: Amnesia; Animals; Anti-Anxiety Agents; Avoidance Learning; Cholinergic Agents; Dizocilpine Maleate; | 1994 |
Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
Topics: Amnesia; Animals; Exploratory Behavior; Habituation, Psychophysiologic; Haloperidol; Learning; Male; | 1994 |
Effects of several amnesic drugs on the habituation of exploratory activity in mice as indexed by horizontal and vertical activities.
Topics: Amnesia; Animals; Behavior, Animal; Butylscopolammonium Bromide; Cycloheximide; Diazepam; Dizocilpin | 1994 |
Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats.
Topics: Acetylcholine; Amnesia; Analysis of Variance; Animals; Haloperidol; Hippocampus; Male; Muscarinic An | 1995 |
SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice.
Topics: Amnesia; Analysis of Variance; Animals; Avoidance Learning; Cognition; Disease Models, Animal; Dizoc | 1997 |
Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
Topics: Amnesia; Amyloid beta-Peptides; Analgesics, Opioid; Animals; Antipsychotic Agents; Avoidance Learnin | 1998 |
The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.
Topics: Amnesia; Animals; Anticonvulsants; Avoidance Learning; Carbon Monoxide; Ethylamines; Guanidines; Hal | 1999 |
The effects of atrial natriuretic peptide on electroconvulsive shock-induced amnesia in rats. Transmitter-mediated action.
Topics: Amnesia; Animals; Atrial Natriuretic Factor; Atropine; Avoidance Learning; Bicuculline; Electroshock | 1991 |
Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice.
Topics: Amnesia; Animals; Behavior, Animal; Butylscopolammonium Bromide; Diazepam; Dizocilpine Maleate; Halo | 1991 |
[Pharmacological correction of ketamine-impaired spatial memory of rats].
Topics: Amnesia; Animals; Aspartic Acid; Haloperidol; Hippocampus; Ketamine; Memory, Short-Term; Physostigmi | 1990 |
[Antagonism of caerulein, a CCK-8 receptor agonist, to the behavioral effects of ketamine in mice and rats].
Topics: Amnesia; Animals; Ataxia; Behavior, Animal; Ceruletide; Haloperidol; Ketamine; Male; Mice; Motor Act | 1988 |
Agitation in closed head injury: haloperidol effects on rehabilitation outcome.
Topics: Amnesia; Brain; Brain Injuries; Coma; Haloperidol; Humans; Prognosis; Psychomotor Agitation; Retrosp | 1985 |